Aurinia Pharmaceuticals (AUPH) Stock: Why The Price Dropped Today

Aurinia Pharmaceuticals (AUPH) Stock: Why The Price Dropped Today
  • The stock price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) fell by over 10% pre-market today. This is why it happened.

The stock price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) fell by over 10% pre-market today. Investors are responding negatively to a Form S-3 from the company. 


The filing reveals a $250 million mixed shelf offering. The company said that the proceeds will be used for clinical development and commercial production of voclosporin, advancing the pipeline, regulatory, additional clinical trials, business development opportunities, capital expenditures, and working capital.


Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.